Patient must maintain NPO status for at least 8 hours. Pre-operative assessment includes echocardiography (TTE/TEE), cardiac catheterization to exclude coronary artery disease, complete blood count, coagulation profile, cross-matching for blood products, and prophylactic antibiotic administration within 60 minutes of incision.
Post-operative care requires intensive care unit monitoring for hemodynamics, management of anticoagulation therapy, pain control, early mobilization, and daily echocardiographic monitoring. Discharge instructions include sternal precautions, wound care, medication compliance, and follow-up cardiology appointments.
Comprehensive Clinical Guide: Mitral Valve Repair (Annuloplasty)
1. Introduction and Overview
Mitral valve repair, specifically through annuloplasty, represents the gold standard in the surgical management of mitral valve disease. Unlike mitral valve replacement (MVR), which involves substituting the native valve with a mechanical or bioprosthetic device, mitral valve repair preserves the patient's own tissue, subvalvular apparatus, and native hemodynamics.
The mitral valve is a complex structure consisting of two leaflets (anterior and posterior), the annulus, chordae tendineae, and papillary muscles. When the annulus—the fibrous ring supporting the leaflets—becomes dilated, the leaflets lose their ability to coapt (close) properly, leading to mitral regurgitation (MR). Annuloplasty is the surgical technique of reinforcing this ring, typically by attaching a prosthetic annuloplasty ring or band, to restore the geometry of the valve, ensure proper leaflet contact, and prevent further annular dilation.
2. Technical Specifications and Mechanisms
The mechanism of annuloplasty is rooted in the restoration of the "saddle shape" and the reduction of the annular circumference.
The Annuloplasty Ring/Band
The prosthetic device used in annuloplasty is designed to reshape the mitral annulus to its physiological dimensions.
* Rigid Rings: Provide maximum structural support but may limit the natural expansion and contraction of the annulus during the cardiac cycle.
* Semi-Rigid/Flexible Rings: Allow for more physiological motion while still providing sufficient stabilization to prevent recurrent dilation.
* Complete vs. Incomplete Bands: Complete rings provide 360-degree support, whereas incomplete bands (C-shaped) are often used to avoid potential injury to the circumflex artery and the conduction system near the fibrous trigones.
Mechanism of Action
- Reduction: The device forces the dilated annulus back to a smaller, more functional diameter.
- Remodeling: It pulls the posterior annulus anteriorly, increasing the leaflet coaptation surface area.
- Stress Redistribution: By stabilizing the annulus, the device offloads the stress on the chordae tendineae and the leaflets themselves, preventing long-term structural degradation.
3. Extensive Clinical Indications and Usage
Annuloplasty is indicated for patients exhibiting symptomatic mitral regurgitation, particularly when the valve anatomy is amenable to repair.
| Indication Type | Specific Condition |
|---|---|
| Degenerative MR | Barlow’s disease, fibroelastic deficiency, or ruptured chordae. |
| Functional MR | Ischemic or dilated cardiomyopathy where the annulus is stretched. |
| Rheumatic Disease | Selected cases where leaflet mobility is preserved. |
| Endocarditis | Repair after localized excision of vegetations (if tissue allows). |
Pre-Operative Preparation
A rigorous pre-operative workup is essential to determine the feasibility of repair versus replacement.
* Transthoracic & Transesophageal Echocardiography (TTE/TEE): Essential for assessing leaflet tethering, prolapse, calcification, and the mechanism of regurgitation.
* Cardiac Catheterization: To assess coronary artery anatomy, particularly in ischemic MR, and to rule out concurrent coronary artery disease (CAD).
* Cardiac MRI: Used in complex cases to evaluate ventricular remodeling and myocardial viability.
* Physical Optimization: Standard surgical clearance, including optimization of blood pressure, glycemic control, and smoking cessation.
4. The Procedure: Step-by-Step Intervention
Mitral valve repair is typically performed via median sternotomy or, increasingly, via minimally invasive right thoracotomy.
- Cardiopulmonary Bypass (CPB): The patient is placed on heart-lung bypass, and cardioplegic arrest is induced.
- Exposure: The left atrium is opened (atriotomy), and the mitral valve is exposed.
- Valve Assessment: The surgeon performs a detailed inspection of the leaflets, chordae, and annulus using the "water test" or saline irrigation to confirm the site of regurgitation.
- Reconstruction (If needed): Before the ring is placed, the surgeon may perform leaflet resections (e.g., quadrangular resection), chordal shortening, or artificial chordae replacement (Gore-Tex loops).
- Annuloplasty Sizing: A sizing tool is used to select the appropriate ring based on the surface area of the anterior leaflet.
- Suture Placement: Interrupted sutures are placed around the mitral annulus.
- Ring Attachment: The prosthetic ring is "parachuted" down the sutures and secured.
- Verification: The heart is de-aired, the cross-clamp is removed, and TEE is used to assess the result. If MR persists, the repair may be adjusted immediately.
5. Post-Operative Recovery and Protocol
Recovery follows a structured cardiothoracic surgery pathway.
- Immediate Post-Op (ICU): Hemodynamic monitoring, weaning from the ventilator (typically within 6–12 hours), and management of anticoagulation.
- Early Recovery (Step-down Unit): Mobilization begins on Post-Op Day 1 or 2. Focus on pulmonary hygiene and pain management.
- Anticoagulation: Unlike mechanical valve replacement, annuloplasty patients generally only require short-term anticoagulation (warfarin or aspirin) for 3–6 months unless they have concurrent atrial fibrillation.
- Long-term Surveillance: Annual echocardiograms are vital to monitor for recurrent MR or ring dehiscence.
6. Risks, Side Effects, and Contraindications
Potential Complications
- Systolic Anterior Motion (SAM): A risk where the anterior leaflet is pushed into the left ventricular outflow tract, causing obstruction.
- Conduction Disturbances: Risk of heart block due to the proximity of the AV node to the annulus.
- Residual MR: If the repair is inadequate.
- Infection: Endocarditis of the prosthetic ring.
- Thromboembolic Events: Rare, but possible in the early post-op period.
Contraindications
- Severe Leaflet Calcification: Makes suturing the ring impossible.
- Extensive Valve Destruction: Due to advanced endocarditis.
- Poor Ventricular Function: If the heart is too weak to tolerate the physiological changes post-repair.
7. Alternative Treatments
- Mitral Valve Replacement (MVR): Using a mechanical or tissue valve. Indicated when repair is not anatomically feasible.
- Transcatheter Edge-to-Edge Repair (TEER): (e.g., MitraClip). A minimally invasive option for high-risk surgical patients.
- Medical Management: Primarily for functional MR, focusing on neurohormonal blockade (ACE inhibitors, beta-blockers) and cardiac resynchronization therapy (CRT).
8. Frequently Asked Questions (FAQ)
1. Is mitral valve repair better than replacement?
Yes. Repair preserves the native valve apparatus, which is crucial for long-term left ventricular function and avoids the need for lifelong anticoagulation associated with mechanical valves.
2. How long does an annuloplasty ring last?
The ring itself is a permanent implant. If the repair is successful, it can last a lifetime, though recurrent MR can occur due to disease progression.
3. Will I need blood thinners for the rest of my life?
Generally, no. Unless you have atrial fibrillation or other underlying conditions, you will typically only need blood thinners for a few months post-surgery.
4. Can this surgery be done robotically?
Yes, many centers offer robotic-assisted mitral valve repair, which is a form of minimally invasive surgery that allows for smaller incisions and faster recovery.
5. How long is the hospital stay?
Most patients stay in the hospital for 4 to 7 days, depending on the surgical approach (sternotomy vs. minimally invasive) and individual recovery speed.
6. What is the success rate?
In experienced centers, the repair rate for degenerative mitral valve disease exceeds 95%, with excellent long-term durability.
7. When can I return to work?
Most patients return to light activities within 4–6 weeks and full normal activity within 3 months.
8. What is the difference between an annuloplasty ring and a band?
An annuloplasty ring is a complete circle, while a band is an incomplete, C-shaped device. Surgeons choose based on the specific anatomy of the valve.
9. What if the valve cannot be repaired during surgery?
The surgeon will discuss this possibility with you before the procedure. If the tissue is too damaged, they will switch to a valve replacement.
10. Can I exercise after the procedure?
Yes. Once cleared by your cardiologist (usually after 6–8 weeks), regular physical activity is encouraged to maintain cardiovascular health.
9. Conclusion
Mitral valve repair via annuloplasty is a sophisticated, highly effective intervention that offers patients a superior quality of life compared to valve replacement. By understanding the underlying anatomy and the precision of the surgical technique, patients can feel confident in the durability and efficacy of this procedure. As surgical techniques continue to evolve toward less invasive approaches, the role of annuloplasty remains central to the future of valvular heart disease treatment.
Disclaimer: This guide is for educational purposes and does not replace professional medical advice. Always consult with your cardiac surgeon or cardiologist regarding your specific health needs.